The membrane-bound DPP IV activity in renal tumors (Figure 1B) decreased significantly in all tumor types we analyzed (CCRCC, ChRCC and RO) when compared with the normal tissue samples. This evidence concerns the gene DPP4 and nonpapillary renal cell carcinoma.